First drug for delusions in Parkinson's patients approved

By Associated Press  |  April 29, 2016

Federal health officials have approved an experimental drug to treat psychotic delusions and behaviors that often afflict patients with Parkinson's disease, the debilitating movement disorder.

Valeant files overdue financial report, ending debt default

By Associated Press  |  April 29, 2016

Valeant Pharmaceuticals resolved its default on some of its $30 billion in debt by finally filing its long-overdue U.S. financial report for 2015 on Friday. The badly tarnished Canadian drugmaker also announced a slate of mostly new nominees for elections to its board in June.

Sanofi makes $9.3 billion bid for Medivation

By Associated Press  |  April 28, 2016

Drugmaker Sanofi says it has made a $9.3 billion bid for San Francisco pharmaceutical firm Medivation, part of the firm's effort to expand its portfolio of cancer treatments.

Shareholders criticize Pfizer over scrapped Allergan deal

By Associated Press  |  April 28, 2016

Just weeks after the collapse of Pfizer's controversial deal to buy fellow drugmaker Allergan and move its headquarters to Ireland, company executives faced sharp criticism from shareholders at their annual meeting.

Valeant CEO will cite 'mistakes' in price-hiking strategy

By Associated Press  |  April 27, 2016

The outgoing CEO of embattled drugmaker Valeant Pharmaceuticals will tell lawmakers Wednesday that he was "too aggressive" and made mistakes in significantly hiking prices for several critical medicines, according to testimony provided to the Associated Press.

Lawmakers blast Valeant for price-gouging tactics

By Associated Press  |  April 27, 2016

Lawmakers accused drugmaker Valeant Pharmaceuticals of gouging patients to reward Wall Street investors at a hearing Wednesday focused on the embattled drugmaker's pricing tactics.

House panel approves bipartisan drug abuse bill

By Associated Press  |  April 27, 2016

The House Judiciary Committee on Wednesday took an election-year swipe at the nation's growing drug addiction problem, approving federal grants that would bolster state and local efforts against the abuse of opioid painkillers.

Senate hearing into Valeant includes top hedge fund investor

By Associated Press  |  April 26, 2016

Senate lawmakers investigating price hikes by the embattled drugmaker Valeant Pharmaceuticals will also question one of the company's leading investors, hedge fund manager William Ackman. A Senate committee holds its third meeting on drug prices on Wednesday.

Novartis profits dip as generic rival challenges cancer drug

By Associated Press  |  April 21, 2016

Swiss pharmaceuticals maker Novartis says net income from continued operations fell 13% in the first quarter as generic competition cut into sales of Gleevec, one of the first very effective cancer medicines.

Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.